BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 36555549)

  • 1. CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension.
    Tomaszewski M; Małkowska P; Sierawska O; Hrynkiewicz R; Mroczek E; Darocha S; Hymos A; Błaszczak P; Grywalska E; Niedźwiedzka-Rystwej P
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High CD200 Expression on T CD4+ and T CD8+ Lymphocytes as a Non-Invasive Marker of Idiopathic Pulmonary Hypertension-Preliminary Study.
    Tomaszewski M; Grywalska E; Topyła-Putowska W; Błaszczak P; Kurzyna M; Roliński J; Kopeć G
    J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33804413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral Blood T Cells of Patients with IPAH Have a Reduced Cytokine-Producing Capacity.
    van Uden D; Koudstaal T; van Hulst JAC; Vink M; van Nimwegen M; van den Toorn LM; Chandoesing PP; van den Bosch AE; Kool M; Hendriks RW; Boomars KA
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank).
    Charoenpong P; Dhillon N; Murnane K; Goeders N; Hall N; Keller C; Bhuiyan MAN; Walter R
    BMJ Open Respir Res; 2023 Dec; 10(1):. PubMed ID: 38061804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic Cell Subsets and Effector Function in Idiopathic and Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    van Uden D; Boomars K; Kool M
    Front Immunol; 2019; 10():11. PubMed ID: 30723471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of cardiopulmonary exercise testing in comparing cardio-pulmonary function among patients with three kinds of pulmonary artery hypertension].
    Zhao Q; Liu Z; Ma X; Zhao Z; Luo Q; Gu Q; Xiong C; Zhang H; Wang Y
    Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(44):3598-601. PubMed ID: 26813372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [End tidal PCO(2) for evaluation of severity of disease in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension].
    Shi X; Yang GL; Chen Y; Guo J; Yang WL; Yuan P; Gong SG; Jiang R; Zhao QH; Wang L; He J; Chen TX; Liu JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Jan; 40(1):34-39. PubMed ID: 28100360
    [No Abstract]   [Full Text] [Related]  

  • 8. Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension.
    Heukels P; Corneth OBJ; van Uden D; van Hulst JAC; van den Toorn LM; van den Bosch AE; Wijsenbeek MS; Boomars KA; Kool M; Hendriks RW
    Thorax; 2021 Dec; 76(12):1209-1218. PubMed ID: 33963088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential serum lipid distribution in IPAH and CHD-PAH patients.
    Chen J; Rathinasabapathy A; Luo J; Yang X; Luo P; Chen Y; Li Z; Li J
    Respir Med; 2022 Jan; 191():106711. PubMed ID: 34890866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension.
    Langleben D; Orfanos SE; Giovinazzo M; Hirsch A; Baron M; Senécal JL; Armaganidis A; Catravas JD
    Arthritis Rheum; 2008 Apr; 58(4):1156-64. PubMed ID: 18383374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of relationship between P wave dispersion and diagnosis of pulmonary arterial hypertension and risk stratification.
    Luo J; Sun J; Xu L; Chen J; Chen Y; Chen W; Qiu H; Luo X; Chen S; Li J
    J Electrocardiol; 2023; 81():94-100. PubMed ID: 37657302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension.
    Hirsch K; Nolley S; Ralph DD; Zheng Y; Altemeier WA; Rhodes CJ; Morrell NW; Wilkins MR; Leary PJ; Rayner SG
    J Heart Lung Transplant; 2023 Feb; 42(2):173-182. PubMed ID: 36470771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic Differences in Connective Tissue Disease-Associated Versus Idiopathic Pulmonary Arterial Hypertension in the PVDOMICS Cohort.
    Simpson CE; Hemnes AR; Griffiths M; Grunig G; Tang WHW; Garcia JGN; Barnard J; Comhair SA; Damico RL; Mathai SC; Hassoun PM;
    Arthritis Rheumatol; 2023 Dec; 75(12):2240-2251. PubMed ID: 37335853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of changes in NT-proBNP, hsTnT and uric acid levels with haemodynamic changes after targeted medical therapies in patients with idiopathic pulmonary arterial hypertension.
    Li WT; Wu CW; Liu JM
    Cardiovasc J Afr; 2022 Jan-Feb 23; 33(1):10-14. PubMed ID: 34851353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry.
    Chazova IY; Martynyuk TV; Valieva ZS; Gratsianskaya SY; Aleevskaya AM; Zorin AV; Nakonechnikov SN
    Biomed Res Int; 2020; 2020():6836973. PubMed ID: 32626754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of pulmonary arterial pressure in patients with connective tissue disease-associated pulmonary arterial hypertension by myocardial perfusion imaging.
    Wang Z; Li J; Wang X; Liu M; Liao M; Zhang C; Shang X
    Ann Noninvasive Electrocardiol; 2022 Mar; 27(2):e12927. PubMed ID: 34908208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors.
    Gu L; Li YY; Gu L; Xie L; Liu HM
    Front Pediatr; 2020; 8():106. PubMed ID: 32296664
    [No Abstract]   [Full Text] [Related]  

  • 19. Professional killer cell deficiencies and decreased survival in pulmonary arterial hypertension.
    Edwards AL; Gunningham SP; Clare GC; Hayman MW; Smith M; Frampton CM; Robinson BA; Troughton RW; Beckert LE
    Respirology; 2013 Nov; 18(8):1271-7. PubMed ID: 23819819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension.
    Sadeghi S; Granton JT; Akhavan P; Pasarikovski CR; Roos AM; Thenganatt J; Moric J; Johnson SR
    Respirology; 2015 Apr; 20(3):481-7. PubMed ID: 25583377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.